Wolf Ruprecht Wiedemeyer

Wolf Ruprecht Wiedemeyer

Company: BridGene Biosciences

Job title: Biology Director


Leveraging the Hippo Pathway for Therapeutic Intervention – Optimizing Translation, Animal Models & Safety 12:00 pm

As we continue to see more success with drugs targeting the Hippo pathway, it is critical that we consider how to optimize translation and safety to the patient. This panel discussion will consider all important elements to nurture the success of Hippo targeted therapies, including debates on topics surrounding advanced animal models, pharmacology and toxicology,…Read more

day: Day Two

Discovery & Development of Novel Covalent TEAD Inhibitors 1:30 pm

Introduction to IMTAC screening platform and BridGene’s covalent library IMTAC screening identifies three distinct TEAD ligands Functional and biochemical characterization of novel TEAD inhibitorsRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.